Quanterix Corporation
- Jurisdiction
United States - ISIN
US74766Q1013 (QTRX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
5
/ 7
Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. Read full profile
Fundamentals
- Net revenue
€106.94M - Gross margin
55.5% - EBIT
-€76.75M - EBIT margin
-71.8% - Net income
-€60.13M - Net margin
-56.2%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| James Anderson |
|
|
|
Sell |
| Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: May 8, 2024 (Q1 2024)